Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Rix

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Cancer Research Communications|June 4, 2026
Targeting GSTZ1 sensitizes KRAS G12C-mutant lung cancer cells by overcoming glutathione and glycolysis pathway rewiringYi Liao, Xueli Li, Min Liu, et al.
Scientific Reports|January 26, 2019
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemiaBrent M Kuenzi, Lily L Remsing Rix, Fumi Kinose, et al.
Oncotarget|December 22, 2017
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancerKatie M Mishall, Thomas C Beadnell, Brent M Kuenzi, et al.
The Journal of Biological Chemistry|April 9, 2005
Functional analyses of oxygenases in jadomycin biosynthesis and identification of JadH as a bifunctional oxygenase/dehydraseYi-Hua Chen, Chen-Chen Wang, Lisa Greenwell, et al.
Iscience|November 21, 2024
SART1 modulates poly-(ADP-ribose) chain accumulation and PARP1 chromatin localizationSamuele Lodovichi, Thales C Nepomuceno, Nicholas T Woods, et al.
Journal of Medicinal Chemistry|February 22, 2002
Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugateTamer A Macky, Carsten Oelkers, Uwe Rix, et al.
Molecular Cancer Therapeutics|January 17, 2016
Target Identification in Small Cell Lung Cancer via Integrated Phenotypic Screening and Activity-Based Protein ProfilingJiannong Li, Bin Fang, Fumi Kinose, et al.
BJR Artificial Intelligence|May 1, 2026
Does artificial intelligence need companionship to assist in drug discovery? The Kirsten rat sarcoma virus studyMourad Stitou, John M Koomen, Denis J Imbody, et al.
Journal of Proteome Research|September 30, 2016
APOSTL: An Interactive Galaxy Pipeline for Reproducible Analysis of Affinity Proteomics DataBrent M Kuenzi, Adam L Borne, Jiannong Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 16, 2011
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazineOliver Brandt, Michael Mildner, Alexander E Egger, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research Communications|June 4, 2026
Targeting GSTZ1 sensitizes KRAS G12C-mutant lung cancer cells by overcoming glutathione and glycolysis pathway rewiringYi Liao, Xueli Li, Min Liu, et al.
Scientific Reports|January 26, 2019
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemiaBrent M Kuenzi, Lily L Remsing Rix, Fumi Kinose, et al.
Oncotarget|December 22, 2017
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancerKatie M Mishall, Thomas C Beadnell, Brent M Kuenzi, et al.
The Journal of Biological Chemistry|April 9, 2005
Functional analyses of oxygenases in jadomycin biosynthesis and identification of JadH as a bifunctional oxygenase/dehydraseYi-Hua Chen, Chen-Chen Wang, Lisa Greenwell, et al.
Iscience|November 21, 2024
SART1 modulates poly-(ADP-ribose) chain accumulation and PARP1 chromatin localizationSamuele Lodovichi, Thales C Nepomuceno, Nicholas T Woods, et al.
Journal of Medicinal Chemistry|February 22, 2002
Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugateTamer A Macky, Carsten Oelkers, Uwe Rix, et al.
Molecular Cancer Therapeutics|January 17, 2016
Target Identification in Small Cell Lung Cancer via Integrated Phenotypic Screening and Activity-Based Protein ProfilingJiannong Li, Bin Fang, Fumi Kinose, et al.
BJR Artificial Intelligence|May 1, 2026
Does artificial intelligence need companionship to assist in drug discovery? The Kirsten rat sarcoma virus studyMourad Stitou, John M Koomen, Denis J Imbody, et al.
Journal of Proteome Research|September 30, 2016
APOSTL: An Interactive Galaxy Pipeline for Reproducible Analysis of Affinity Proteomics DataBrent M Kuenzi, Adam L Borne, Jiannong Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 16, 2011
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazineOliver Brandt, Michael Mildner, Alexander E Egger, et al.
Pageof 9